Clinical Trial Update: PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE [Phase 2]

View source ↗

Summary

Phase II neoadjuvant trial of letrozole and lapatinib in HER2-positive, hormone receptor-positive operable breast cancer; the study is terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• Letrozole (letrozole)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-07-10